Browse 472 Federal Consumer Protection Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Consumer Protection grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| September 11th, 2019 |
Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed |
Food and Drug Administration |
| July 12th, 2019 |
New Directions in Advancing Locally Led Development |
Agency for International Development |
| May 30th, 2021 |
Locally Led Development Innovation |
Agency for International Development |
| July 29th, 2019 |
Implementation of U.S. Food Safety Modernization Act - Identifying, Researching, and Implementing Alternative Methods to Expand the Reach across the Global Supply Chain (U01) - Clinical Trials Not Allowed |
Food and Drug Administration |
| July 29th, 2019 |
Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional |
Food and Drug Administration |
| July 16th, 2019 |
BJA FY 19 Data-led Governing: Raising the Bar for States' Criminal Justice Policy and Practice |
Bureau of Justice Assistance |
| July 17th, 2019 |
Information Sharing System for State-Regulated Drug Compounding Activities (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| July 10th, 2019 |
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| July 10th, 2019 |
National Project to Support and Promote Consistent Implementation of the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption (U18) |
Food and Drug Administration |
| July 2nd, 2019 |
BJA FY 19 The Intellectual Property Enforcement Program: Protecting Public Health, Safety, and the Economy from Counterfeit Goods and Product Piracy |
Bureau of Justice Assistance |
| June 25th, 2019 |
Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional |
Food and Drug Administration |
| June 11th, 2019 |
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities. (U01) Clinical Trial |
Food and Drug Administration |
| June 3rd, 2019 |
Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trial Required |
Food and Drug Administration |
| June 3rd, 2019 |
Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01 Clinical Trial Required) |
Food and Drug Administration |
| May 28th, 2019 |
Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade Development Facility (STDF) (U01 Clinical Trial Not Allowed) |
Food and Drug Administration |
| May 28th, 2019 |
BJA FY 19 Comprehensive Opioid Abuse Program Training and Technical Assistance (TTA) Program |
Bureau of Justice Assistance |
| May 21st, 2019 |
Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18 Clinical Trial Not Allowed) |
Food and Drug Administration |
| May 20th, 2019 |
Implementation of the Animal Feed Regulatory Program Standards (U18 Clinical Trial Not Allowed) |
Food and Drug Administration |
| April 5th, 2021 |
Advancing Manufacturing Processing and Control Strategies for Drug Substances and Drug Products (U01)- Clinical Trial Optional |
Food and Drug Administration |
| April 30th, 2019 |
Development, Implementation, and Management of a Funding System to support the Grade A Milk Safety Program and National Shellfish Sanitation Program (U18) |
Food and Drug Administration |
|
| April 5th, 2021 |
Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional |
Food and Drug Administration |
| June 5th, 2019 |
Pool Safely Grant Program (PSGP) |
Consumer Product Safety Commission |
| April 22nd, 2019 |
Enhancing Regulatory Science for the Risk Based Quality Assessment of Complex Products (U01) - Clinical Trials Optional |
Food and Drug Administration |
| April 22nd, 2019 |
Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional) |
Food and Drug Administration |
| April 11th, 2019 |
Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed) |
Food and Drug Administration |
| April 11th, 2019 |
Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required) |
Food and Drug Administration |
| April 11th, 2019 |
Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed) |
Food and Drug Administration |
| April 4th, 2019 |
Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required) Activity Code |
Food and Drug Administration |
| April 4th, 2019 |
Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01) Clinical Trial Optional |
Food and Drug Administration |
| April 4th, 2019 |
Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed) |
Food and Drug Administration |
| October 15th, 2018 |
Request for Information (RFI): FDA Standard Core Clinical Outcome Assessments and Endpoints |
Food and Drug Administration |
| July 22nd, 2018 |
TEST-OPPORTUNITY |
General Dynamics Information Technology |
| January 16th, 2021 |
Minor Use Minor Species Development of Drugs (R01) |
Food and Drug Administration |
| August 13th, 2018 |
Strengthening Global Competency and Capacity in Inspectional Approaches and Good Manufacturing Practices (GMP) (U01) |
Food and Drug Administration |
| June 22nd, 2018 |
Notice of Intent to Award Yuma Crossing National Heritage Area Corporation |
Bureau of Reclamation |
| June 20th, 2018 |
Development of a virtual bioequivalence trial simulation platform that integrates population pharmacokinetic modeling algorithms into physiologically-based pharmacokinetic models (U01) |
Food and Drug Administration |
| July 18th, 2018 |
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U19) |
Food and Drug Administration |
| June 14th, 2018 |
BJA FY 18 The Intellectual Property Enforcement Program: Protecting Public Health, Safety, and the Economy from Counterfeit Goods and Product Piracy |
Bureau of Justice Assistance |
| June 14th, 2018 |
BJA FY 18 Economic, High-Technology, White Collar, and Internet Crime Prevention National Training and Technical Assistance Program |
Bureau of Justice Assistance |
| June 25th, 2018 |
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act |
Food and Drug Administration |
